Archives: Speakers

Iain is an Account Director within Catalent’s Clinical Supply Services and he has worked in clinical trials and clinical drug development since 2010. Iain has worked with Sponsors, CROs and academic institutions of all sizes supporting them with their early phase clinical studies through to commercialization. Ranging from comparator & commercial drug sourcing to IMP blinding, primary and secondary packaging, global storage and distribution solutions, IMP forecasting, through to clinical supplies management. Iain has previously worked within Catalent’s global Client Services team undertaking requirements and quotes, working with Catalent’s customers around the globe, from virtual/small biotech and pharma to the larger industry household names. With over a decade of experience within the industry, Iain previously achieved a BSc(Hons) in Biology from the Manchester Metropolitan University in the UK.

Sylvain has acquired extensive experience in IRT through various roles within Calyx over his 10+ years in the company. It allows him to grasp where IRT can make a difference based on the protocol design, and accordingly advise clinical trial teams what solution is the most suitable for each trial. Sylvain is a key member of the Calyx IRT product core team, acting as an advocate for end-users, as well as sharing his vision with the team to push the boundaries of IRT.

Sébastien Coppe has a Master of Engineering in Applied Mathematics. He obtained his PhD by creating a pre-diagnostic tool for patients suffering from Alzheimer’s disease, leveraging AI to model patients’ brain behaviour.
Sébastien has been leading the N-SIDE Life Sciences activities for 10 years, providing optimization services to more than 80 pharmaceutical and biotech companies. He has been supporting them in their change management journey towards digitalization. He is passionate about increasing Pharma R&D efficiency by leveraging data and artificial intelligence, reducing waste and clinical development timelines by bringing end-to-end clinical supply chain optimization and proactive risk assessment for patients.

David Lorenzo, Business Development Director, joined LSNE (a PCI company) in October 2019 with a strong track record in sales and business development within the pharmaceutical industry. David’s 18+ years of experience span through API and CDMO sales, licensing and alliance management, with a deep expertise on contract manufacturing of injectable drug products. Prior to joining PCI, David held alliance management and business development positions at Slayback Pharma, Interquim, Chemo and Curia (former companies), where he performed outstanding results in various positions. David studied at the University of Valladolid (Spain) and holds a degree in Organic Chemistry.

Jerome Detreille holds a PhD in Pharmacy and is the Senior Director of New Business Development at PCI. Jerome has over 20 years’ experience in selling services for both conventional and highly potent drugs covering all dosage forms from oral solid dose and drug delivery platforms to sterile injectables. Jerome has held a number of senior positions and prior to joining PCI, he was part of the Executive Team at Penn Pharma and he worked at Catalent Pharma Solutions as Head of European Sales and Business Development for sterile injectables.

Amaury Jeandrain has a Master’s Degree in Business Engineering with a specialization in supply chain optimization. He joined Clinigen in 2015, then N-SIDE in 2016 where he last  held the position of VP of Strategy for clinical supply solutions.

Over the past decade, his objective has been to make clinical trial supply chains more efficient by redefining CTS strategies and driving measurable performance improvements. His expertise also includes forecasting, planning, waste reduction, and shortage risk mitigation.

Since 2024, while accompanying his wife on humanitarian missions abroad (Niger, then Colombia), Amaury has continued his work as a CTS advisor and trainer, partnering with pharmaceutical companies worldwide to enhance clinical supply performance.

Marcel Besier has spent the last 20 years of his career in professional services and program management teams working with global clients implementing IT solutions. As Director of Services Delivery, he oversees the professional services team responsible for project management, account management, and IRT services delivery for Suvoda’s customers in Europe. Marcel holds a dual degree in International Business Administration and General Management.

At MSD from 2012 and before worked with comparator sourcing since 2004 at a few wholesalers and a CMO. Started career in product management of medical devices and OTC products. M.Sc. in Engineering in 1995 and proficient in English, German, Italian and Swedish.

After graduating in business management, Thierry Gillard has been involved in logistics and supply management for over 20 years. He made his first step in clinical packaging and distribution in 2007 with a major CMO involved worldwide in clinical supplies management. During 10 years with this CMO, he has been contributing to the set-up of a wide array of clinical studies and packaging designs from phase I manually distributed studies, to large Phase III IRT controlled studies, including supply forecasting and Campaigns management. As a Senior Clinical Supplies Manager for Santhera Pharmaceuticals in Switzerland since 2017, a company specializing in neuro-ophthalmological, neuromuscular und pulmonary conditions, widely relying on external vendors, he is in charge of the selection, qualification and oversight of CMO’s providing clinical packaging, distribution and IRT services.

Dan Pavitt has worked in Information Technology since 2001 specialising in eClinical Solutions since 2006. A Software Engineer by training, Dan has helped countless clinical teams implement and realise value from a range of eClinical products including Randomisation and Trial Supply Management (RTSM/IRT/IxRS), Electronic Clinical Outcome Assessment (eCOA) and Clinical Trial Management Systems (CTMS) tools. Dan has worked for a range of Pharma companies and technology vendors, he joined Medidata in 2019 and is currently responsible for the Rave RTSM Solution in Europe.